IIT Kanpur experts reveal insights to lower cholesterol with lesser side-effects | Education

by

Researchers at the Indian Institute of Technology (IIT) Kanpur have revealed new insights into understanding how cholesterol-lowering drugs like Niacin work at a molecular level.

Researchers at the Indian Institute of Technology (IIT) have revealed new insights into understanding how cholesterol-lowering drugs like Niacin work at a molecular level. The research has the potential to lead to the development of new drugs to lower cholesterol with fewer side effects.

According to a press release issued by the institute, the team of researchers from the Department of Biological Sciences and Bioengineering led by Prof. Arun K. Shukla, were able to visualize the key target receptor molecule activated by Niacin and other related drugs. The research has the potential to lead to the development of new drugs to lower cholesterol with fewer side effects.

Hindustan Times – your fastest source for breaking news! Read now.

The findings of the research have been published in the international journal, Nature Communications, the release informed.

Speaking on the research, Prof. Shukla explained that Niacin is a commonly prescribed drug to lower bad cholesterol and triglycerides while increasing good cholesterol. “In many patients, the drug causes side effects such as skin redness and itching, referred to as flushing response. This leads to patients stopping their treatment with adverse effects on their cholesterol levels,” he added.

Also read: UPSC CDS 1 2023: Marks of non-qualified, willing candidates announced

Prof. Shukla highlighted that the visualization of the receptor molecules with Niacin at the molecular level lays the groundwork for creating new drugs that maintain efficacy while minimizing undesirable reactions, adding that the results will help in developing related drugs for cholesterol and drugs for other conditions such as multiple sclerosis.

Also read: Study abroad: Macquarie University announces scholarships up to AUD 40,000 to students from India & Sri Lanka

Prof. S. Ganesh, Director of IIT Kanpur, termed the research as an important breakthrough as it deepens the understanding of drug-receptor interactions and opens new avenues for the design of better therapeutic agents.

Notably, the study has been supported by the Science and Engineering Research Board (SERB). The research team includes Dr Manish Yadav, Parishmita Sarma, Jagannath Maharana, Manisankar Ganguly, Sudha Mishra, Annu Dalal, Nashrah Zaidi, Sayantan Saha, Gargi Mahajan, Vinay Singh, Saloni Sharma, and Dr Ramanuj Banerjee, spearheaded by Prof Shukla.

Also read: TANCET 2024 MBA, MCA entrance test answer key out, know how to check

Read original article here

Denial of responsibility! Pioneer Newz is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – [email protected]. The content will be deleted within 24 hours.

Leave a Comment